Back to companies

Mayne Pharma Group Ltd: Patents

View up-to-date information on Mayne Pharma Group Ltd patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
CA2876909C Grant ITRACONAZOLE COMPOSITIONS AND DOSAGE FORMS, AND METHODS OF USING THE SAME A61K31/496; A61K47/30; A61K47/38; A61K9/0053; A61K9/0065; A61K9/14; A61K9/20; A61K9/48; A61K9/4866; A61P1/04; A61P17/00; A61P31/10; A61P35/00 August 16, 2022
EP3814349A4 Search Report HEMMUNG DES HEDGEHOG-WEGS ZUR BEHANDLUNG VON RISIKOREICHEM BASALZELLKARZINOM ODER RISIKOREICHEM BASALZELLKARZINOM-NEVUS-SYNDROM A61K31/337; A61K31/496; A61K47/02; A61K47/32; A61K47/36; A61K47/38; A61K9/0053; A61K9/146 March 02, 2022
US11053274B2 Grant Process for the production of estetrol intermediates A61P5/00; A61P5/30; C07J1/0059; C07J1/0066; C07J13/005; C07J51/00; Y02P20/55 July 06, 2021
US11020407B2 Grant Corticosteroid containing foam compositions and method of manufacture thereof A61K31/573; A61K31/58; A61K47/06; A61K47/10; A61K47/12; A61K47/44; A61K9/0014; A61K9/122; A61P17/00; A61P17/04; A61P17/06; A61P29/00; A61P37/08; B65B31/003; B65B63/08; B65D83/752 June 01, 2021
EP3814349A1 Application HEMMUNG DES HEDGEHOG-WEGS ZUR BEHANDLUNG VON RISIKOREICHEM BASALZELLKARZINOM ODER RISIKOREICHEM BASALZELLKARZINOM-NEVUS-SYNDROM A61K31/337; A61K31/496; A61K47/02; A61K47/32; A61K47/36; A61K47/38; A61K9/0053; A61K9/146 May 05, 2021
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Contact Us

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code